Search Results

GLP-1 RA Use Linked to Lower Rates of Hyperkalemia in Type 2 Diabetes

• Source: MPR Monthly Prescribing Reference. August 13, 2024

Record details

Hyperkalemia Risk Possible With Recalled Potassium Chloride ER Capsules

• Authors : Park, Brian

• Source: MPR Monthly Prescribing Reference. June 26, 2024

Record details

Kionex Suspension Now Available for Hyperkalemia Treatment

• Authors : Park, Brian

• Source: MPR Monthly Prescribing Reference. May 21, 2024

Record details

Veltassa Approval Expanded to Pediatric Patients With Hyperkalemia

• Authors : Ernst, Diana

• Source: MPR Monthly Prescribing Reference. October 12, 2023

Record details

RAAS Inhibition Combos May Up Hyperkalemia Risk in Diabetic Kidney Disease

• Authors : Persaud, Natasha

• Source: MPR Monthly Prescribing Reference. July 22, 2023

Record details

Suboptimal RAASi Therapy After Hyperkalemia Ups Cardiorenal Risks

• Authors : Persaud, Natasha

• Source: MPR Monthly Prescribing Reference. March 4, 2023

Record details

Trimethoprim-Sulfamethoxazole vs Amoxicillin Ups Hyperkalemia Risk

• Authors : Persaud, Natasha

• Source: MPR Monthly Prescribing Reference. December 13, 2022

Record details

Patiromer Use for Acute Hyperkalemia Characterized

• Authors : Persaud, Natasha

• Source: MPR Monthly Prescribing Reference. November 22, 2022

Record details

RAAS Inhibitor Discontinuation After Hyperkalemia Tied to Adverse Outcomes

• Authors : Persaud, Natasha

• Source: MPR Monthly Prescribing Reference. November 19, 2022

Record details

Patiromer Effective for Hyperkalemia Across CKD Stages

• Authors : Persaud, Natasha

• Source: MPR Monthly Prescribing Reference. August 23, 2022

Record details